Precore mutation enhances viral replication to facilitate persistent infection especially in HBeAg-negative patients

Guixin Li,Danli Yang,Xin Liu,Ting Zhang,Hui Liu,Jun Zou,Zimeng Xu,Xiangmei Chen,Lizhong Dai,Hongsong Chen,Fengmin Lu

DOI: https://doi.org/10.1016/j.virs.2024.03.003

IF: 6.947

2024-03-15

Virologica Sinica

Abstract:Highlights • PC mutation is relevant with a higher serum HBV DNA level in HBeAg-negative patients. • PC mutation enables preC RNA to exert pgRNA-like function to enhance HBV replication. • BCP+PC mutations promote HBV replication via various mechanisms. • BCP+PC mutations contribute to maintenance of cccDNA pool in humanized mice. • BCP+PC mutations exert direct cytopathic effects in humanized mice. Naturally occurred precore (PC, G1896A) and/or basal core promoter (BCP, A1762T/G1764A) mutations are prevalent in chronic HBV-infected patients, especially those under HBeAg-negative status. However, the replicative capacity of HBV with PC/BCP mutations remains ambiguous. Herein, meta-analysis showed that, only under HBeAg-negative status, the serum HBV DNA load in patients with PC mutation was 7.41-fold higher than those without the mutation. Both PC mutation alone and BCP+PC mutations promoted HBV replication in cell and hydrodynamic injection mouse models. In human hepatocyte chimeric mouse model, BCP+PC mutations led to elevated replicative capacity and intrahepatic core protein accumulation. Mechanistically, preC RNA harboring PC mutation could serve as mRNA to express core and P proteins, and such pgRNA-like function favored the maintenance of cccDNA pool under HBeAg-negative status. Additionally, BCP+PC mutations induced more extensive and severe human hepatocyte damage as well as activated endoplasmic reticulum stress and TNF signaling pathway in livers of chimeric mice. This study indicates that HBeAg-negative patients should be monitored on HBV mutations regularly and are expected to receive early antiviral treatment to prevent disease progression.

virology